**Core Concept**
Adenoid hypertrophy is a condition characterized by the enlargement of the adenoid tissue in the nasopharynx, often leading to nasal obstruction, recurrent otitis media, and other respiratory complications. The primary goal of treatment is to alleviate symptoms and prevent complications.

**Why the Correct Answer is Right**
Nasal decongestants, such as oxymetazoline or phenylephrine, work by reducing nasal mucosal swelling and congestion. They act on the alpha-adrenergic receptors in the nasal mucosa, causing vasoconstriction and subsequent reduction in nasal secretions. This provides temporary relief from nasal obstruction and facilitates breathing. In the context of adenoid hypertrophy, nasal decongestants are often the first line of treatment, especially in children.

**Why Each Wrong Option is Incorrect**
**Option B:** Antibiotics are not the primary treatment for adenoid hypertrophy, as the condition is not caused by a bacterial infection. While antibiotics may be used to treat secondary infections, such as otitis media, they do not address the underlying cause of adenoid hypertrophy.

**Option C:** Beta-blockers, such as propranolol, are not indicated in the treatment of adenoid hypertrophy. Beta-blockers are used to treat various cardiovascular conditions, including hypertension and tachyarrhythmias, but have no role in managing nasal congestion or adenoid hypertrophy.

**Option D:** Beta-2 agonists, such as salbutamol, are used to treat bronchospasm in conditions like asthma. They do not have a role in managing adenoid hypertrophy or nasal congestion.

**Clinical Pearl / High-Yield Fact**
Nasal decongestants can cause rebound nasal congestion, also known as rhinitis medicamentosa, if used for prolonged periods. This is a common exam trap, and students should be aware of the potential risks and limitations of nasal decongestants.

**Correct Answer:**
✓ Correct Answer: A. Nasal decongestants